Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Amortization of Deferred Charges (2022 - 2023)

Werewolf Therapeutics (HOWL) has disclosed Amortization of Deferred Charges for 2 consecutive years, with $60000.0 as the latest value for Q1 2023.

  • On a quarterly basis, Amortization of Deferred Charges changed N/A to $60000.0 in Q1 2023 year-over-year; TTM through Dec 2023 was $60000.0, a 70.44% decrease, with the full-year FY2023 number at $60000.0, down 70.44% from a year prior.
  • Amortization of Deferred Charges was $60000.0 for Q1 2023 at Werewolf Therapeutics, down from $203000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $203000.0 in Q4 2022 to a low of $60000.0 in Q1 2023.